Clinical Trial Update: Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial update assessing biodistribution and safety of PET probes [18F]FPRGD2 and [18F]FPPRGD2 in cancer patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Glioblastoma
• Non-small Cell Lung Cancer
• Other Cancers

Drugs mentioned

• [18F]FPPRGD2
• [18F]FPRGD2

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer, Non-Small-Cell Lung Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-01-12